nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—ADRB3—type 2 diabetes mellitus	0.172	0.416	CbGaD
Epinephrine—ADRA2A—type 2 diabetes mellitus	0.0779	0.188	CbGaD
Epinephrine—TNF—type 2 diabetes mellitus	0.0738	0.178	CbGaD
Epinephrine—CYP1A2—type 2 diabetes mellitus	0.0541	0.131	CbGaD
Epinephrine—CYP3A4—type 2 diabetes mellitus	0.0358	0.0866	CbGaD
Epinephrine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0292	0.0803	CbGbCtD
Epinephrine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0265	0.0729	CbGbCtD
Epinephrine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0252	0.0692	CbGbCtD
Epinephrine—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0229	0.0628	CbGbCtD
Epinephrine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0213	0.0585	CbGbCtD
Epinephrine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0175	0.0481	CbGbCtD
Epinephrine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0168	0.0461	CbGbCtD
Epinephrine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0128	0.0352	CbGbCtD
Epinephrine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0117	0.0322	CbGbCtD
Epinephrine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0109	0.03	CbGbCtD
Epinephrine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0105	0.0288	CbGbCtD
Epinephrine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00949	0.0261	CbGbCtD
Epinephrine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00927	0.0255	CbGbCtD
Epinephrine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00927	0.0255	CbGbCtD
Epinephrine—SLC22A1—Metformin—type 2 diabetes mellitus	0.00911	0.025	CbGbCtD
Epinephrine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00855	0.0235	CbGbCtD
Epinephrine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00836	0.023	CbGbCtD
Epinephrine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00826	0.0227	CbGbCtD
Epinephrine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00756	0.0208	CbGbCtD
Epinephrine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00747	0.0205	CbGbCtD
Epinephrine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00745	0.0205	CbGbCtD
Epinephrine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00707	0.0194	CbGbCtD
Epinephrine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00702	0.0193	CbGbCtD
Epinephrine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00682	0.0187	CbGbCtD
Epinephrine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00673	0.0185	CbGbCtD
Epinephrine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00596	0.0164	CbGbCtD
Epinephrine—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00542	0.241	CbGeAlD
Epinephrine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00539	0.0148	CbGbCtD
Epinephrine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00482	0.0132	CbGbCtD
Epinephrine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00474	0.013	CbGbCtD
Epinephrine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00434	0.0119	CbGbCtD
Epinephrine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00408	0.0112	CbGbCtD
Epinephrine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00392	0.0108	CbGbCtD
Epinephrine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00392	0.0108	CbGbCtD
Epinephrine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0037	0.0102	CbGbCtD
Epinephrine—ADRBK1—peripheral nervous system—type 2 diabetes mellitus	0.00297	0.132	CbGeAlD
Epinephrine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00276	0.00758	CbGbCtD
Epinephrine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00252	0.00693	CbGbCtD
Epinephrine—PAH—kidney—type 2 diabetes mellitus	0.00104	0.0463	CbGeAlD
Epinephrine—ADRBK1—cardiovascular system—type 2 diabetes mellitus	0.000811	0.0361	CbGeAlD
Epinephrine—ADRBK1—kidney—type 2 diabetes mellitus	0.000793	0.0353	CbGeAlD
Epinephrine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000747	0.0333	CbGeAlD
Epinephrine—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000731	0.0326	CbGeAlD
Epinephrine—ADRBK1—adipose tissue—type 2 diabetes mellitus	0.000715	0.0319	CbGeAlD
Epinephrine—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.000678	0.214	CrCbGaD
Epinephrine—PAH—liver—type 2 diabetes mellitus	0.000657	0.0293	CbGeAlD
Epinephrine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000555	0.0247	CbGeAlD
Epinephrine—SLC22A2—kidney—type 2 diabetes mellitus	0.000488	0.0217	CbGeAlD
Epinephrine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000475	0.0212	CbGeAlD
Epinephrine—Arbutamine—ADRB3—type 2 diabetes mellitus	0.000469	0.148	CrCbGaD
Epinephrine—ADRA1B—kidney—type 2 diabetes mellitus	0.000467	0.0208	CbGeAlD
Epinephrine—SLC22A1—kidney—type 2 diabetes mellitus	0.000345	0.0154	CbGeAlD
Epinephrine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000339	0.0151	CbGeAlD
Epinephrine—Dipivefrin—ADRA2A—type 2 diabetes mellitus	0.00032	0.101	CrCbGaD
Epinephrine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000311	0.0138	CbGeAlD
Epinephrine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000299	0.0133	CbGeAlD
Epinephrine—SLC22A5—retina—type 2 diabetes mellitus	0.000289	0.0129	CbGeAlD
Epinephrine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000285	0.0127	CbGeAlD
Epinephrine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000282	0.0126	CbGeAlD
Epinephrine—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000273	0.0121	CbGeAlD
Epinephrine—Droxidopa—ADRB3—type 2 diabetes mellitus	0.00027	0.0849	CrCbGaD
Epinephrine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000268	0.0119	CbGeAlD
Epinephrine—ADRA2C—kidney—type 2 diabetes mellitus	0.00025	0.0111	CbGeAlD
Epinephrine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000248	0.0111	CbGeAlD
Epinephrine—Hypokalaemia—Orlistat—type 2 diabetes mellitus	0.000246	0.0025	CcSEcCtD
Epinephrine—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.000245	0.0772	CrCbGaD
Epinephrine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000244	0.0108	CbGeAlD
Epinephrine—Mental disorder—Sitagliptin—type 2 diabetes mellitus	0.000243	0.00247	CcSEcCtD
Epinephrine—Erythema—Glimepiride—type 2 diabetes mellitus	0.000242	0.00246	CcSEcCtD
Epinephrine—Cerebrovascular accident—Irbesartan—type 2 diabetes mellitus	0.00024	0.00244	CcSEcCtD
Epinephrine—SLC22A5—kidney—type 2 diabetes mellitus	0.000239	0.0107	CbGeAlD
Epinephrine—Tension—Glimepiride—type 2 diabetes mellitus	0.000237	0.00241	CcSEcCtD
Epinephrine—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000237	0.00241	CcSEcCtD
Epinephrine—Tension—Sitagliptin—type 2 diabetes mellitus	0.000237	0.00241	CcSEcCtD
Epinephrine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000236	0.0105	CbGeAlD
Epinephrine—Nervousness—Glimepiride—type 2 diabetes mellitus	0.000235	0.00239	CcSEcCtD
Epinephrine—Nervousness—Sitagliptin—type 2 diabetes mellitus	0.000234	0.00238	CcSEcCtD
Epinephrine—Lightheadedness—Ramipril—type 2 diabetes mellitus	0.000234	0.00238	CcSEcCtD
Epinephrine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000233	0.0104	CbGeAlD
Epinephrine—Renal impairment—Losartan—type 2 diabetes mellitus	0.000232	0.00236	CcSEcCtD
Epinephrine—Hyperglycaemia—Gliclazide—type 2 diabetes mellitus	0.000232	0.00236	CcSEcCtD
Epinephrine—Nausea—Miglitol—type 2 diabetes mellitus	0.000231	0.00235	CcSEcCtD
Epinephrine—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.00023	0.00234	CcSEcCtD
Epinephrine—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.000229	0.00233	CcSEcCtD
Epinephrine—Sweating increased—Orlistat—type 2 diabetes mellitus	0.000227	0.00231	CcSEcCtD
Epinephrine—Norepinephrine—ADRB3—type 2 diabetes mellitus	0.000227	0.0715	CrCbGaD
Epinephrine—Hypoglycaemia—Losartan—type 2 diabetes mellitus	0.000226	0.0023	CcSEcCtD
Epinephrine—Acute coronary syndrome—Gliclazide—type 2 diabetes mellitus	0.000226	0.0023	CcSEcCtD
Epinephrine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000225	0.01	CbGeAlD
Epinephrine—Renal failure—Gliclazide—type 2 diabetes mellitus	0.000225	0.00229	CcSEcCtD
Epinephrine—Myocardial infarction—Gliclazide—type 2 diabetes mellitus	0.000225	0.00229	CcSEcCtD
Epinephrine—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.000224	0.00228	CcSEcCtD
Epinephrine—Hypertension—Glipizide—type 2 diabetes mellitus	0.000224	0.00228	CcSEcCtD
Epinephrine—Agitation—Glimepiride—type 2 diabetes mellitus	0.000222	0.00226	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000221	0.00225	CcSEcCtD
Epinephrine—Sweating—Gliclazide—type 2 diabetes mellitus	0.00022	0.00224	CcSEcCtD
Epinephrine—Mental disorder—Bromocriptine—type 2 diabetes mellitus	0.00022	0.00223	CcSEcCtD
Epinephrine—SLC22A1—liver—type 2 diabetes mellitus	0.000218	0.0097	CbGeAlD
Epinephrine—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000216	0.00962	CbGeAlD
Epinephrine—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000214	0.00218	CcSEcCtD
Epinephrine—Tension—Bromocriptine—type 2 diabetes mellitus	0.000214	0.00218	CcSEcCtD
Epinephrine—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000214	0.00217	CcSEcCtD
Epinephrine—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.000214	0.00217	CcSEcCtD
Epinephrine—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.000212	0.00216	CcSEcCtD
Epinephrine—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.000211	0.00215	CcSEcCtD
Epinephrine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000211	0.00214	CcSEcCtD
Epinephrine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000211	0.00214	CcSEcCtD
Epinephrine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.00021	0.00938	CbGeAlD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00021	0.00214	CcSEcCtD
Epinephrine—Sweating increased—Metformin—type 2 diabetes mellitus	0.000209	0.00213	CcSEcCtD
Epinephrine—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000209	0.00212	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000209	0.00212	CcSEcCtD
Epinephrine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000208	0.00212	CcSEcCtD
Epinephrine—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000208	0.00212	CcSEcCtD
Epinephrine—Renal failure—Valsartan—type 2 diabetes mellitus	0.000207	0.00211	CcSEcCtD
Epinephrine—Hypoaesthesia—Gliclazide—type 2 diabetes mellitus	0.000205	0.00208	CcSEcCtD
Epinephrine—Renal failure—Orlistat—type 2 diabetes mellitus	0.000205	0.00208	CcSEcCtD
Epinephrine—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000204	0.00208	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00207	CcSEcCtD
Epinephrine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000203	0.00206	CcSEcCtD
Epinephrine—Agitation—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00204	CcSEcCtD
Epinephrine—Erythema—Glyburide—type 2 diabetes mellitus	0.000199	0.00203	CcSEcCtD
Epinephrine—Renal impairment—Ramipril—type 2 diabetes mellitus	0.000199	0.00203	CcSEcCtD
Epinephrine—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000199	0.00202	CcSEcCtD
Epinephrine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000198	0.00883	CbGeAlD
Epinephrine—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000197	0.002	CcSEcCtD
Epinephrine—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000196	0.00199	CcSEcCtD
Epinephrine—Methyldopa—ADRA2A—type 2 diabetes mellitus	0.000195	0.0616	CrCbGaD
Epinephrine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000195	0.00199	CcSEcCtD
Epinephrine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000195	0.00198	CcSEcCtD
Epinephrine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000194	0.00866	CbGeAlD
Epinephrine—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000194	0.00198	CcSEcCtD
Epinephrine—Cerebrovascular accident—Ramipril—type 2 diabetes mellitus	0.000193	0.00197	CcSEcCtD
Epinephrine—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00196	CcSEcCtD
Epinephrine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000193	0.00196	CcSEcCtD
Epinephrine—Drowsiness—Metformin—type 2 diabetes mellitus	0.000192	0.00195	CcSEcCtD
Epinephrine—Insomnia—Glipizide—type 2 diabetes mellitus	0.000191	0.00195	CcSEcCtD
Epinephrine—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000191	0.00194	CcSEcCtD
Epinephrine—Flushing—Gliclazide—type 2 diabetes mellitus	0.000191	0.00194	CcSEcCtD
Epinephrine—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000191	0.00194	CcSEcCtD
Epinephrine—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.00019	0.00193	CcSEcCtD
Epinephrine—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00019	0.00193	CcSEcCtD
Epinephrine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000189	0.00193	CcSEcCtD
Epinephrine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000189	0.00193	CcSEcCtD
Epinephrine—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000189	0.00192	CcSEcCtD
Epinephrine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00192	CcSEcCtD
Epinephrine—Somnolence—Glipizide—type 2 diabetes mellitus	0.000188	0.00191	CcSEcCtD
Epinephrine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000188	0.00191	CcSEcCtD
Epinephrine—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000188	0.00191	CcSEcCtD
Epinephrine—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000187	0.0019	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00188	CcSEcCtD
Epinephrine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000184	0.00187	CcSEcCtD
Epinephrine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000183	0.00186	CcSEcCtD
Epinephrine—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000183	0.00186	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000183	0.00186	CcSEcCtD
Epinephrine—Nausea—Acarbose—type 2 diabetes mellitus	0.000182	0.00185	CcSEcCtD
Epinephrine—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.00018	0.00183	CcSEcCtD
Epinephrine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.00018	0.00801	CbGeAlD
Epinephrine—Erythema—Gliclazide—type 2 diabetes mellitus	0.000179	0.00182	CcSEcCtD
Epinephrine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000179	0.00182	CcSEcCtD
Epinephrine—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000178	0.00181	CcSEcCtD
Epinephrine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000178	0.00181	CcSEcCtD
Epinephrine—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000178	0.00181	CcSEcCtD
Epinephrine—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000177	0.0018	CcSEcCtD
Epinephrine—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000177	0.0018	CcSEcCtD
Epinephrine—Tension—Gliclazide—type 2 diabetes mellitus	0.000176	0.00179	CcSEcCtD
Epinephrine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000175	0.00179	CcSEcCtD
Epinephrine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000175	0.00178	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000175	0.00178	CcSEcCtD
Epinephrine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00178	CcSEcCtD
Epinephrine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000175	0.00178	CcSEcCtD
Epinephrine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000174	0.00177	CcSEcCtD
Epinephrine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000174	0.00177	CcSEcCtD
Epinephrine—Levonordefrin—ADRA2A—type 2 diabetes mellitus	0.000173	0.0545	CrCbGaD
Epinephrine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00176	CcSEcCtD
Epinephrine—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000172	0.00175	CcSEcCtD
Epinephrine—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000171	0.00174	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00017	0.00173	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00017	0.00173	CcSEcCtD
Epinephrine—Renal failure—Losartan—type 2 diabetes mellitus	0.000167	0.0017	CcSEcCtD
Epinephrine—ADRA1A—liver—type 2 diabetes mellitus	0.000166	0.00739	CbGeAlD
Epinephrine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000166	0.00168	CcSEcCtD
Epinephrine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000165	0.00167	CcSEcCtD
Epinephrine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000164	0.00166	CcSEcCtD
Epinephrine—Sweating—Losartan—type 2 diabetes mellitus	0.000163	0.00166	CcSEcCtD
Epinephrine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000163	0.00165	CcSEcCtD
Epinephrine—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000162	0.00164	CcSEcCtD
Epinephrine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00164	CcSEcCtD
Epinephrine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00163	CcSEcCtD
Epinephrine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00016	0.00163	CcSEcCtD
Epinephrine—Flushing—Metformin—type 2 diabetes mellitus	0.00016	0.00163	CcSEcCtD
Epinephrine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00016	0.00162	CcSEcCtD
Epinephrine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.00016	0.00162	CcSEcCtD
Epinephrine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00161	CcSEcCtD
Epinephrine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000158	0.00161	CcSEcCtD
Epinephrine—ADRA2C—liver—type 2 diabetes mellitus	0.000158	0.00704	CbGeAlD
Epinephrine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000157	0.0016	CcSEcCtD
Epinephrine—CYP3A4—kidney—type 2 diabetes mellitus	0.000157	0.007	CbGeAlD
Epinephrine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000155	0.00157	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00156	CcSEcCtD
Epinephrine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000152	0.00155	CcSEcCtD
Epinephrine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000152	0.00155	CcSEcCtD
Epinephrine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000152	0.00154	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000151	0.00154	CcSEcCtD
Epinephrine—SLC22A5—liver—type 2 diabetes mellitus	0.000151	0.00674	CbGeAlD
Epinephrine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000151	0.00153	CcSEcCtD
Epinephrine—Erythema—Metformin—type 2 diabetes mellitus	0.00015	0.00152	CcSEcCtD
Epinephrine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000146	0.00149	CcSEcCtD
Epinephrine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000145	0.00148	CcSEcCtD
Epinephrine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000145	0.00148	CcSEcCtD
Epinephrine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000144	0.00146	CcSEcCtD
Epinephrine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000144	0.00146	CcSEcCtD
Epinephrine—Renal failure—Ramipril—type 2 diabetes mellitus	0.000144	0.00146	CcSEcCtD
Epinephrine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000144	0.00146	CcSEcCtD
Epinephrine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000143	0.00146	CcSEcCtD
Epinephrine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000143	0.00146	CcSEcCtD
Epinephrine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000143	0.00145	CcSEcCtD
Epinephrine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000142	0.00144	CcSEcCtD
Epinephrine—Flushing—Losartan—type 2 diabetes mellitus	0.000142	0.00144	CcSEcCtD
Epinephrine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000141	0.00144	CcSEcCtD
Epinephrine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000141	0.00144	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000141	0.00143	CcSEcCtD
Epinephrine—Chest pain—Valsartan—type 2 diabetes mellitus	0.00014	0.00143	CcSEcCtD
Epinephrine—Sweating—Ramipril—type 2 diabetes mellitus	0.00014	0.00142	CcSEcCtD
Epinephrine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00014	0.00142	CcSEcCtD
Epinephrine—Phenylephrine—CYP1A2—type 2 diabetes mellitus	0.000139	0.0439	CrCbGaD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000139	0.00142	CcSEcCtD
Epinephrine—Tension—Irbesartan—type 2 diabetes mellitus	0.000139	0.00141	CcSEcCtD
Epinephrine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000138	0.00141	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000137	0.0014	CcSEcCtD
Epinephrine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000137	0.0014	CcSEcCtD
Epinephrine—CYP1A2—liver—type 2 diabetes mellitus	0.000137	0.00611	CbGeAlD
Epinephrine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000137	0.00139	CcSEcCtD
Epinephrine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000134	0.00137	CcSEcCtD
Epinephrine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000134	0.00136	CcSEcCtD
Epinephrine—Erythema—Losartan—type 2 diabetes mellitus	0.000133	0.00135	CcSEcCtD
Epinephrine—Palpitations—Metformin—type 2 diabetes mellitus	0.000132	0.00135	CcSEcCtD
Epinephrine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000132	0.00134	CcSEcCtD
Epinephrine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000132	0.00134	CcSEcCtD
Epinephrine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000131	0.00134	CcSEcCtD
Epinephrine—Tension—Losartan—type 2 diabetes mellitus	0.000131	0.00133	CcSEcCtD
Epinephrine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000131	0.00133	CcSEcCtD
Epinephrine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00013	0.00133	CcSEcCtD
Epinephrine—CYP2C9—liver—type 2 diabetes mellitus	0.00013	0.0058	CbGeAlD
Epinephrine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00013	0.00132	CcSEcCtD
Epinephrine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00013	0.00132	CcSEcCtD
Epinephrine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00013	0.00132	CcSEcCtD
Epinephrine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00013	0.00132	CcSEcCtD
Epinephrine—Hypertension—Metformin—type 2 diabetes mellitus	0.000129	0.00132	CcSEcCtD
Epinephrine—Nervousness—Losartan—type 2 diabetes mellitus	0.000129	0.00131	CcSEcCtD
Epinephrine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000129	0.00131	CcSEcCtD
Epinephrine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000128	0.0013	CcSEcCtD
Epinephrine—Chest pain—Metformin—type 2 diabetes mellitus	0.000128	0.0013	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000127	0.00129	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000126	0.00128	CcSEcCtD
Epinephrine—Nausea—Glipizide—type 2 diabetes mellitus	0.000126	0.00128	CcSEcCtD
Epinephrine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000125	0.00128	CcSEcCtD
Epinephrine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000125	0.00127	CcSEcCtD
Epinephrine—Agitation—Losartan—type 2 diabetes mellitus	0.000122	0.00124	CcSEcCtD
Epinephrine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000122	0.00124	CcSEcCtD
Epinephrine—Droxidopa—ADRA2A—type 2 diabetes mellitus	0.000122	0.0384	CrCbGaD
Epinephrine—Flushing—Ramipril—type 2 diabetes mellitus	0.000122	0.00124	CcSEcCtD
Epinephrine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000121	0.00124	CcSEcCtD
Epinephrine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000121	0.00123	CcSEcCtD
Epinephrine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00012	0.00122	CcSEcCtD
Epinephrine—Insomnia—Orlistat—type 2 diabetes mellitus	0.00012	0.00122	CcSEcCtD
Epinephrine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00012	0.00122	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00012	0.00122	CcSEcCtD
Epinephrine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000119	0.00121	CcSEcCtD
Epinephrine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000119	0.00121	CcSEcCtD
Epinephrine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000119	0.00121	CcSEcCtD
Epinephrine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000118	0.0012	CcSEcCtD
Epinephrine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000118	0.0012	CcSEcCtD
Epinephrine—Palpitations—Losartan—type 2 diabetes mellitus	0.000118	0.0012	CcSEcCtD
Epinephrine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000117	0.00119	CcSEcCtD
Epinephrine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000117	0.00119	CcSEcCtD
Epinephrine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000117	0.00119	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000116	0.00118	CcSEcCtD
Epinephrine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.00117	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000115	0.00117	CcSEcCtD
Epinephrine—Erythema—Ramipril—type 2 diabetes mellitus	0.000114	0.00116	CcSEcCtD
Epinephrine—Chest pain—Losartan—type 2 diabetes mellitus	0.000113	0.00115	CcSEcCtD
Epinephrine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00115	CcSEcCtD
Epinephrine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000113	0.00115	CcSEcCtD
Epinephrine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000113	0.00115	CcSEcCtD
Epinephrine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000112	0.00114	CcSEcCtD
Epinephrine—Tension—Ramipril—type 2 diabetes mellitus	0.000112	0.00114	CcSEcCtD
Epinephrine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000112	0.00113	CcSEcCtD
Epinephrine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000111	0.00113	CcSEcCtD
Epinephrine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00011	0.00112	CcSEcCtD
Epinephrine—Somnolence—Metformin—type 2 diabetes mellitus	0.000109	0.00111	CcSEcCtD
Epinephrine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000107	0.00108	CcSEcCtD
Epinephrine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000106	0.00108	CcSEcCtD
Epinephrine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00108	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000106	0.00107	CcSEcCtD
Epinephrine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000105	0.00107	CcSEcCtD
Epinephrine—Agitation—Ramipril—type 2 diabetes mellitus	0.000105	0.00107	CcSEcCtD
Epinephrine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000104	0.00105	CcSEcCtD
Epinephrine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000103	0.00105	CcSEcCtD
Epinephrine—Norepinephrine—ADRA2A—type 2 diabetes mellitus	0.000103	0.0323	CrCbGaD
Epinephrine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000103	0.00104	CcSEcCtD
Epinephrine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.00101	CcSEcCtD
Epinephrine—CYP3A4—liver—type 2 diabetes mellitus	9.93e-05	0.00442	CbGeAlD
Epinephrine—Insomnia—Losartan—type 2 diabetes mellitus	9.82e-05	0.000999	CcSEcCtD
Epinephrine—Paraesthesia—Losartan—type 2 diabetes mellitus	9.75e-05	0.000992	CcSEcCtD
Epinephrine—Chest pain—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000988	CcSEcCtD
Epinephrine—Nausea—Glyburide—type 2 diabetes mellitus	9.67e-05	0.000984	CcSEcCtD
Epinephrine—Dizziness—Gliclazide—type 2 diabetes mellitus	9.67e-05	0.000983	CcSEcCtD
Epinephrine—Somnolence—Losartan—type 2 diabetes mellitus	9.65e-05	0.000982	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000981	CcSEcCtD
Epinephrine—Salbutamol—CYP3A4—type 2 diabetes mellitus	9.48e-05	0.0299	CrCbGaD
Epinephrine—Vomiting—Gliclazide—type 2 diabetes mellitus	9.29e-05	0.000945	CcSEcCtD
Epinephrine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000929	CcSEcCtD
Epinephrine—Tachycardia—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000925	CcSEcCtD
Epinephrine—Skin disorder—Ramipril—type 2 diabetes mellitus	9.05e-05	0.00092	CcSEcCtD
Epinephrine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9e-05	0.000916	CcSEcCtD
Epinephrine—Dizziness—Valsartan—type 2 diabetes mellitus	8.88e-05	0.000903	CcSEcCtD
Epinephrine—Dizziness—Orlistat—type 2 diabetes mellitus	8.77e-05	0.000893	CcSEcCtD
Epinephrine—Nausea—Gliclazide—type 2 diabetes mellitus	8.68e-05	0.000883	CcSEcCtD
Epinephrine—Vomiting—Valsartan—type 2 diabetes mellitus	8.54e-05	0.000869	CcSEcCtD
Epinephrine—Vomiting—Orlistat—type 2 diabetes mellitus	8.44e-05	0.000858	CcSEcCtD
Epinephrine—Insomnia—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000857	CcSEcCtD
Epinephrine—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.36e-05	0.000851	CcSEcCtD
Epinephrine—Somnolence—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000842	CcSEcCtD
Epinephrine—Dizziness—Metformin—type 2 diabetes mellitus	8.09e-05	0.000823	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000818	CcSEcCtD
Epinephrine—Nausea—Valsartan—type 2 diabetes mellitus	7.98e-05	0.000811	CcSEcCtD
Epinephrine—Nausea—Orlistat—type 2 diabetes mellitus	7.88e-05	0.000802	CcSEcCtD
Epinephrine—Vomiting—Metformin—type 2 diabetes mellitus	7.78e-05	0.000791	CcSEcCtD
Epinephrine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000776	CcSEcCtD
Epinephrine—Vomiting—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000746	CcSEcCtD
Epinephrine—Nausea—Metformin—type 2 diabetes mellitus	7.26e-05	0.000739	CcSEcCtD
Epinephrine—Dizziness—Losartan—type 2 diabetes mellitus	7.18e-05	0.000731	CcSEcCtD
Epinephrine—Norepinephrine—CYP1A2—type 2 diabetes mellitus	7.13e-05	0.0225	CrCbGaD
Epinephrine—Vomiting—Losartan—type 2 diabetes mellitus	6.91e-05	0.000702	CcSEcCtD
Epinephrine—Nausea—Irbesartan—type 2 diabetes mellitus	6.85e-05	0.000697	CcSEcCtD
Epinephrine—Dopamine—CYP1A2—type 2 diabetes mellitus	6.63e-05	0.0209	CrCbGaD
Epinephrine—Nausea—Losartan—type 2 diabetes mellitus	6.45e-05	0.000656	CcSEcCtD
Epinephrine—Dizziness—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000626	CcSEcCtD
Epinephrine—Vomiting—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000602	CcSEcCtD
Epinephrine—Nausea—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000563	CcSEcCtD
Epinephrine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	1.61e-06	1.64e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.61e-06	1.64e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.61e-06	1.64e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.61e-06	1.63e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.61e-06	1.63e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.61e-06	1.63e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	1.63e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.6e-06	1.63e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.59e-06	1.62e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.59e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.59e-06	1.62e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.59e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.59e-06	1.62e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.59e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.59e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.59e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.58e-06	1.61e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.58e-06	1.6e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.57e-06	1.6e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.57e-06	1.6e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.57e-06	1.59e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.57e-06	1.59e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.55e-06	1.57e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.55e-06	1.57e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.54e-06	1.57e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.54e-06	1.56e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.53e-06	1.56e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.53e-06	1.56e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.53e-06	1.55e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.53e-06	1.55e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.53e-06	1.55e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.51e-06	1.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.5e-06	1.52e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.49e-06	1.52e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.49e-06	1.51e-05	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.49e-06	1.51e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.49e-06	1.51e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.48e-06	1.5e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.48e-06	1.5e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.47e-06	1.49e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.47e-06	1.49e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.47e-06	1.49e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.46e-06	1.49e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.46e-06	1.48e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.46e-06	1.48e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.44e-06	1.46e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.44e-06	1.46e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.44e-06	1.46e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.43e-06	1.46e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.43e-06	1.45e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.42e-06	1.45e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.42e-06	1.45e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.42e-06	1.44e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.42e-06	1.44e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.42e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.42e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.41e-06	1.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.41e-06	1.43e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.41e-06	1.43e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.39e-06	1.42e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.39e-06	1.42e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.39e-06	1.41e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.38e-06	1.4e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.38e-06	1.4e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.38e-06	1.4e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.37e-06	1.4e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.37e-06	1.4e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.37e-06	1.4e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.37e-06	1.39e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.36e-06	1.38e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.36e-06	1.38e-05	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.36e-06	1.38e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.35e-06	1.37e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.35e-06	1.37e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.35e-06	1.37e-05	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.34e-06	1.37e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.34e-06	1.37e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.34e-06	1.36e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.34e-06	1.36e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.34e-06	1.36e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.33e-06	1.35e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.33e-06	1.35e-05	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.33e-06	1.35e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.32e-06	1.34e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.32e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.31e-06	1.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.3e-06	1.32e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.3e-06	1.32e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.29e-06	1.31e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	1.31e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.28e-06	1.3e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.28e-06	1.3e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.28e-06	1.3e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.28e-06	1.3e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.27e-06	1.29e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.27e-06	1.29e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.26e-06	1.28e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.26e-06	1.28e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.26e-06	1.28e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.25e-06	1.26e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.23e-06	1.25e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.21e-06	1.22e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.21e-06	1.22e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.19e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.19e-06	1.21e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.19e-06	1.21e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-06	1.19e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.17e-06	1.19e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.17e-06	1.19e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-06	1.18e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.16e-06	1.18e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-06	1.18e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.15e-06	1.17e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-06	1.16e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.14e-06	1.16e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.14e-06	1.16e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.14e-06	1.16e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.13e-06	1.15e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.13e-06	1.14e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	1.14e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.12e-06	1.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.12e-06	1.14e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-06	1.13e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.11e-06	1.12e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.1e-06	1.12e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.09e-06	1.1e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-06	1.1e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.08e-06	1.1e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.07e-06	1.09e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.07e-06	1.09e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-06	1.08e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.06e-06	1.08e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.06e-06	1.08e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.06e-06	1.07e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-06	1.07e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.05e-06	1.07e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.05e-06	1.07e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.05e-06	1.07e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.05e-06	1.06e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.04e-06	1.06e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.06e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-06	1.04e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.03e-06	1.04e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.02e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.02e-06	1.03e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.01e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.01e-06	1.03e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1e-06	1.02e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.97e-07	1.01e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	9.84e-07	9.99e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.69e-07	9.84e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.66e-07	9.81e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	9.61e-07	9.76e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.55e-07	9.7e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.54e-07	9.69e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.5e-07	9.65e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.47e-07	9.63e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.45e-07	9.6e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.45e-07	9.6e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.42e-07	9.57e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.35e-07	9.5e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.26e-07	9.41e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.23e-07	9.37e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	9.19e-07	9.34e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	9.19e-07	9.34e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	9.17e-07	9.32e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	9.13e-07	9.28e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	9.06e-07	9.2e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	8.96e-07	9.1e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.8e-07	8.94e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.69e-07	8.83e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	8.66e-07	8.79e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.57e-07	8.71e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.53e-07	8.66e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.47e-07	8.6e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	8.41e-07	8.54e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.3e-07	8.44e-06	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	8.28e-07	8.41e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.26e-07	8.39e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	8.21e-07	8.34e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	8.12e-07	8.25e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	8.09e-07	8.22e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	8.06e-07	8.18e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	8e-07	8.13e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.99e-07	8.11e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.89e-07	8.01e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.87e-07	7.99e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.86e-07	7.98e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.86e-07	7.98e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.82e-07	7.94e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	7.72e-07	7.84e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.72e-07	7.84e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.72e-07	7.84e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.3e-07	7.42e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.28e-07	7.39e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.21e-07	7.32e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.19e-07	7.3e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.19e-07	7.3e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.12e-07	7.23e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.05e-07	7.16e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.91e-07	7.02e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.74e-07	6.84e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.63e-07	6.73e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	6.54e-07	6.65e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.38e-07	6.48e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.34e-07	6.44e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.06e-07	6.16e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.06e-07	6.16e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.93e-07	6.02e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.89e-07	5.98e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.55e-07	5.63e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.47e-07	5.56e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	4.23e-07	4.29e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.61e-07	3.67e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.79e-07	2.83e-06	CbGpPWpGaD
